Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
about
Effects of maternal and placental inflammation on retinopathy of prematurity.The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey.Training fellows for retinopathy of prematurity care: a Web-based survey.Risk factors for retinopathy of prematurity: insights from outlier infants.Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): four-years of screening with telemedicine.Intravitreal Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Several Years On.Haemoglobin level at birth is associated with short term outcomes and mortality in preterm infants.Allosteric regulation of pathologic angiogenesis: potential application for angiogenesis-related blindness.Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infantsOne-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.Incidence and severity of retinopathy of prematurity in Turkey.Treatment for retinopathy of prematurity in an infant with adenoviral conjunctivitis.Accuracy of retinopathy of prematurity image-based diagnosis by pediatric ophthalmology fellows: implications for training.Evaluation of vascular disease progression in retinopathy of prematurity using static and dynamic retinal imagesPreeclampsia and Retinopathy of Prematurity in Very-Low-Birth-Weight Infants: A Population-Based StudyComparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor MydriasisScreening Retinopathy of Prematurity in Extremely Low Birth Weight Infants in China and the Need for Earlier Screening Times.Mechanisms and management of retinopathy of prematurity.Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.Evaluation of Visunex Medical's PanoCam(TM) LT and PanoCam(TM) Pro wide-field imaging systems for the screening of ROP in newborn infants.Predictive algorithms for early detection of retinopathy of prematurity.Incidence of retinopathy of prematurity in southwestern China and analysis of risk factorsSpontaneous regression of retinopathy of prematurity: incidence and predictive factors.Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands.Histological and Immunohistochemical Retinal Changes Following the Intravitreal Injection of Aflibercept, Bevacizumab and Ranibizumab in Newborn Rabbits.
P2860
Q33859631-EC4C885B-5DFB-496C-BA34-BB4C2DDD8AC5Q34229923-857C4503-031A-401A-A5B1-8A797C514C5BQ34242307-1742D680-8698-4651-BC8B-10DFC20652D7Q34282973-CB9E9935-890E-4131-A0CD-9C02BA432607Q34553717-75553365-04AF-4106-A256-E3C8F8D6776FQ35002314-B1284471-BDAF-4C15-81F8-30BE9C5FEDB6Q35015955-68DD8AC3-E6F4-4B8F-89DD-8F76CAA83124Q35084192-225AE881-7389-4C45-A322-037138C14F2DQ35087725-4E442460-928E-4BE7-81EA-0CC872335C19Q35404915-DB2D8652-7B3E-4262-B572-9E83DA2B4C93Q35600440-66D458D6-AA0E-4CB1-A317-33F53D9E4A13Q35601352-6B1D5514-7462-47F8-A423-FCD3E206E818Q35619330-C2ADE15D-7843-49A1-8412-CC82D681FCF7Q35696918-E0AE0E2B-F8BC-4158-A5BC-4F02143EC0E8Q35847377-DD0AE482-DA1D-4934-9744-472E819ABA82Q36078573-DA3F36FF-82A6-4A85-A80F-FC9B89E8244FQ36404785-670A9A44-6EE9-4F3A-8C5E-B4E2A00C6EB8Q37575457-B2DE72D2-BEB1-46B2-94B1-860CAF03DA4FQ38069895-755E6C37-738A-446E-8859-F495B939A260Q38373964-B51FAFEF-6FA1-4509-A9B8-7E927696EB53Q38899534-6F7ACCB6-80B9-4F42-A16A-177032B59A88Q40692698-F7189F30-CFA8-4D84-BA5E-030640B2C7D6Q41856754-D686E643-7FA6-4A90-A4AC-C924F3D0D336Q42574480-587C6E55-3F7D-4E0F-82B2-6B17855170AEQ43716714-8B4E13A9-704C-4F35-B6A9-BA52034574D9Q51697739-8AEF368B-A811-40F9-B614-CF1827970A37
P2860
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@ast
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@en
type
label
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@ast
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@en
prefLabel
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@ast
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@en
P2093
P1476
Incidence of retinopathy of prematurity in the United States: 1997 through 2005.
@en
P2093
Eleonora M Lad
John M Morton
Tina Hernandez-Boussard
P304
P356
10.1016/J.AJO.2009.04.018
P407
P577
2009-07-09T00:00:00Z